| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |